Cambridge
United Kingdom
58
2026-05-28
The entities that hold a legal rights for patent applications filed by inventor HOWARD Steven:
Steven HOWARD from Cambridge, GB has applied for patents for these inventions. The list has both pending applications and granted patents:
PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES
#2 | 2026-05-212-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER
#3 | 2026-04-16PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS
#4 | 2025-09-25BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY
#5 | 2025-03-20ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY
#6 | 2025-03-06ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION AND PROCESS FOR MAKING THEM
#7 | 2024-11-07BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS
#8 | 2024-08-08SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT
#9 | 2024-07-18SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT
#10 | 2024-06-20BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY
#11 | 2024-02-08PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES
#12 | 2023-09-07Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them
#13 | 2023-07-20Bicyclic heterocycle compounds and their uses in therapy
#14 | 2023-02-16PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS
#15 | 2023-01-19Benzolactam compounds as protein kinase inhibitors
#16 | 2022-11-17Heterobicyclic compounds for inhibiting the activity of SHP2
#17 | 2022-06-30Bicyclic heterocycle compounds and their uses in therapy
#18 | 2022-04-07ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY
#19 | 2022-03-01Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
#20 | 2021-09-09Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
#21 | 2021-08-19PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES
#22 | 2021-04-29Bicyclic heterocycle compounds and their uses in therapy
#23 | 2021-04-15Pharmaceutical compounds
#24 | 2021-04-08Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them
#25 | 2020-10-15Bicyclic heterocycle compounds and their uses in therapy
#26 | 2020-08-06ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY
#27 | 2020-03-12Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
#28 | 2019-12-12BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY
#29 | 2019-02-21Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
#30 | 2019-02-14Benzolactam compounds as protein kinase inhibitors
#31 | 2019-01-17Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
#32 | 2018-10-04Arylcyclohexyl pyrazoles as NRF2 regulators
#33 | 2018-06-07PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES
#34 | 2018-03-08Bicyclic heterocycle compounds and their uses in therapy
#35 | 2017-11-23BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY
#36 | 2017-08-10Bicyclic heterocycle compounds and their uses in therapy
#37 | 2017-06-29PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES
#38 | 2017-02-02Bicyclic heterocycle compounds and their uses in therapy
#39 | 2016-03-24Bicyclic heterocycle compounds and their uses in therapy
#40 | 2015-12-10Bicyclic heterocycle compounds and their uses in therapy
#41 | 2015-10-15Bicyclic heterocycle compounds and their uses in therapy
#42 | 2015-09-24Bicyclic heterocycle compounds and their uses in therapy
#43 | 2015-09-17Bicyclic heterocycle compounds and their uses in therapy
#44 | 2014-06-26Bicyclic heterocycle compounds and their uses in therapy
#45 | 2014-05-15Pyrrolopyrimidine compounds and their uses
#46 | 2014-02-13Bicyclic heterocycle compounds and their uses in therapy
#47 | 2014-01-09BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
#48 | 2012-07-26Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
#49 | 2012-04-26Imidazole derivatives and their use as modulators of cyclin dependent kinases
#50 | 2011-09-15BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
#51 | 2011-06-23Pyrrolopyrimidine compounds and their uses
#52 | 2010-08-19Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase Inhibitors
#53 | 2010-06-24PYRAZOLE DERIVATIVES AS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASES
#54 | 2010-04-29Pyrrolopyrimidine compounds and their uses
#55 | 2010-01-07PHARMACEUTICAL COMPOUNDS
#56 | 2008-06-05Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
#57 | 2007-06-14Benzimidazole derivatives and their use as protein kinase inhibitors
#58 | 2005-04-12Heterocyclic mutilin esters and their use as antibacterials
605083 ⎘